89 related articles for article (PubMed ID: 12904675)
1. Rasch measurement in the assessment of amytrophic lateral sclerosis patients.
Norquist JM; Fitzpatrick R; Jenkinson C
J Appl Meas; 2003; 4(3):249-57. PubMed ID: 12904675
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the 40-item Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40) with a short-form five-item version (ALSAQ-5) in a longitudinal survey.
Jenkinson C; Fitzpatrick R; Swash M; Jones G
Clin Rehabil; 2007 Mar; 21(3):266-72. PubMed ID: 17329284
[TBL] [Abstract][Full Text] [Related]
3. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
[TBL] [Abstract][Full Text] [Related]
4. [Validity and clinical applicability of the Japanese version of amyotrophic lateral sclerosis--assessment questionnaire 40 (ALSAQ-40)].
Yamaguchi T; Ohbu S; Saito M; Ito Y; Moriwaka F; Tashiro K; Ohashi Y; Fukuhara S
No To Shinkei; 2004 Jun; 56(6):483-94. PubMed ID: 15328837
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in amyotrophic lateral sclerosis: determining a meaningful deterioration.
Norquist JM; Fitzpatrick R; Jenkinson C
Qual Life Res; 2004 Oct; 13(8):1409-14. PubMed ID: 15503836
[TBL] [Abstract][Full Text] [Related]
6. Measurement of decline of functioning in persons with amyotrophic lateral sclerosis: responsiveness and possible applications of the Functional Independence Measure, Barthel Index, Rehabilitation Activities Profile and Frenchay Activities Index.
De Groot IJ; Post MW; Van Heuveln T; Van Den Berg LH; Lindeman E
Amyotroph Lateral Scler; 2006 Sep; 7(3):167-72. PubMed ID: 16963406
[TBL] [Abstract][Full Text] [Related]
7. Validity of the Dutch version of the Amyotrophic Lateral Sclerosis Assessment Questionnaire, ALSAQ-40, ALSAQ-5.
Maessen M; Post MW; Maillé R; Lindeman E; Mooij R; Veldink JH; van den Berg LH
Amyotroph Lateral Scler; 2007 Apr; 8(2):96-100. PubMed ID: 17453637
[TBL] [Abstract][Full Text] [Related]
8. Deriving summary indices of health status from the Amyotrophic Lateral Sclerosis Assessment Questionnaires (ALSAQ-40 and ALSAQ-5).
Jenkinson C; Norquist JM; Fitzpatrick R
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):242-5. PubMed ID: 12531959
[TBL] [Abstract][Full Text] [Related]
9. Interpreting change scores on the Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40).
Jenkinson C; Peto V; Jones G; Fitzpatrick R
Clin Rehabil; 2003 Jul; 17(4):380-5. PubMed ID: 12785246
[TBL] [Abstract][Full Text] [Related]
10. Validation of quality of life instruments in ALS.
Bourke SC; McColl E; Shaw PJ; Gibson GJ
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Mar; 5(1):55-60. PubMed ID: 15204025
[TBL] [Abstract][Full Text] [Related]
11. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
12. The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS.
Simmons Z; Felgoise SH; Bremer BA; Walsh SM; Hufford DJ; Bromberg MB; David W; Forshew DA; Heiman-Patterson TD; Lai EC; McCluskey L
Neurology; 2006 Nov; 67(9):1659-64. PubMed ID: 17101900
[TBL] [Abstract][Full Text] [Related]
13. [Handicap and quality of life evaluation in amyotrophic lateral sclerosis].
Sancho PO; Boisson D
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S205-4S207. PubMed ID: 17128112
[TBL] [Abstract][Full Text] [Related]
14. Integrating preferences into health status assessment for amyotrophic lateral sclerosis: the ALS Utility Index.
Beusterien K; Leigh N; Jackson C; Miller R; Mayo K; Revicki D
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Sep; 6(3):169-76. PubMed ID: 16183558
[TBL] [Abstract][Full Text] [Related]
15. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
Tartaglia MC; Rowe A; Findlater K; Orange JB; Grace G; Strong MJ
Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
[TBL] [Abstract][Full Text] [Related]
16. ALS: Family caregiver needs and quality of life.
Williams MT; Donnelly JP; Holmlund T; Battaglia M
Amyotroph Lateral Scler; 2008 Oct; 9(5):279-86. PubMed ID: 18608102
[TBL] [Abstract][Full Text] [Related]
17. ALSFRS and appel ALS scores: discordance with disease progression.
Voustianiouk A; Seidel G; Panchal J; Sivak M; Czaplinski A; Yen A; Appel SH; Lange DJ
Muscle Nerve; 2008 May; 37(5):668-72. PubMed ID: 18288708
[TBL] [Abstract][Full Text] [Related]
18. Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers.
Lo Coco G; Lo Coco D; Cicero V; Oliveri A; Lo Verso G; Piccoli F; La Bella V
J Neurol Sci; 2005 Nov; 238(1-2):11-7. PubMed ID: 16109426
[TBL] [Abstract][Full Text] [Related]
19. Assessing the responsiveness of measures of oral health-related quality of life.
Locker D; Jokovic A; Clarke M
Community Dent Oral Epidemiol; 2004 Feb; 32(1):10-8. PubMed ID: 14961835
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies between self-ratings of and satisfaction with oral health in two older adult populations.
Locker D; Gibson B
Community Dent Oral Epidemiol; 2005 Aug; 33(4):280-8. PubMed ID: 16008635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
